The recent article of Spadea et al. 1, 2 and Toker et al. 3 evaluated the efficacy of accelerated corneal crosslinking (AXL) under different treatment protocols, and the relationship between CXL efficacy and the demarcation line (DL) depth based on available measured data. 1, 2 The sudden-drop of DL depth at high intensity (>45 mW/cm 2 ) has the similar feature as the AXL efficacy reported by Wernli et al. 4 However, it is clinically unclear whether DL depth is proportional to the crosslink depth or the CXL efficacy. 1-3 Moreover, controversial results of AXL efficacy were reported due to inconsistent protocols which were not optimized. To improve the efficacy of AXL, Lin proposed a new protocol called riboflavin (Rf) concentration-controlled method (CCM), 5 in which extra Rf drops are applied to the cornea, at every crosslink time (T*), during the UV exposure, having a frequency defined as
In
, curve B for extended dose (6.2 J/cm 2 ) has a larger z* than curve A (dose of 5.4 J/cm 2 ). It is also predicted by Lin's formula for crosslink depth 5 which is proportional to light dose, rather than light intensity. Modern protocol has also suggested to use a higher dose of 7.2 J/cm 2 , replacing the Dresden 5.4 J/cm 2 (operation manual of KXL, Avedro Inc.). 2. Epi-on is less efficient than epi-off due to limited diffusion depth (D) and the extra absorption of the epithelium; and epi-on CXL with iontophoresis has a larger z* due to improved diffusion depth (D), comparing data 1 and data 2 of Figure 1 . This feature is also shown in Lin's efficacy-formula, 7 where higher D has higher value of F(z) ¼ F(z) ¼ 1 -0.5z/D and leads to higher efficacy. 3. Curve 2 of Figure 2 represents the conventional protocol having resupply the Rf drops every 4 minutes. Therefore, it has the similar profile as curve A of Figure 1 . This feature indicates that CXL efficacy is proportionally related to the DL depth. The recent article of Spadea et al. 2 also concluded that the depth of DL is an indirect measurement of CXL penetration within the stroma, although ''the deeper, the better'' requires further clinical long-term studies. 4. Both CXL efficacy and DL depth have a cutoff maximum intensity, under the noncontrolled Dresden protocol, as reported by Wernli et al. 4 It should be noted that the theoretical curve 4 (with controlled t' ¼ 0.5 minute, or Fdrop ¼ 3 to 4) gives the optimal efficacy comparable to CCM. 5 
In contrast to the conventional belief (by Hafezi and
Kling et al.) that oxygen-mediated type-II plays the critical role of CXL, Kamaev et al. 8 kinetic model showed that CXL is predominated by type-I, while oxygen (or type-II) only plays a limited and transient role. Lin's 3-pathway model 9 showed mathematical details of the role of oxygen, supporting the claim of Kamaev et al. 8 In addition, a recent clinical study of Lombardo et al. 10 showed a simple-exponential kinetic of RF concentration also implied that, in ambient environment (with approximately 21% partial pressure of oxygen), nonoxygen-mediated type-I mechanism is predominant. 6. The conventional Dresden protocol, extra Rf drops (with a frequency Fdrop ¼ 10-15) instilled during the UV exposure. This too-often Fdrop will reduce the effective dose and CXL efficacy. Some modern protocols propose not to apply any extra Rf drops (with Fdrop ¼ 0), however, has less efficacy than that of optimal CCM 5 which requires Fdrop ¼ 3 to 5 for high intensity AXL (18-50 mW/cm 2 ). 7. Extension of exposure time (or dose) in AXL may increase the crosslink depth (z) and improve the efficacy governed a crosslinked stroma volume 7 ¼ depth · strength. Higher Rf concentration (C 0 ) achieves higher efficacy, predicted by c-Ceff formula, 7 was also clinically reported by O'Brart et al. 11 Therefore, new clinical studies of DL-depth for a wider range of C 0 ¼ 0.1% to 0.3%, and under the CCM protocol might lead to a breakthrough of the AXL efficacy and justify the accuracy of CCM for optimal efficacy.
Jui-teng Lin
New Vision, Inc., Taipei, Taiwan. E-mail: jtlin55@gmail.com
